Molecular structure of Anagrelide-13C3
Anagrelide-13C3
Alternate Names:
6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one-13C3; BL-4162A-13C3; BMY-26538-01-13C3; Agrylin-13C3; Tromboreductin-13C3; Xagrid-13C3
Application:
Anagrelide-13C3 is a labeled type III phosphodiesterase inhibitor
Molecular Weight:
259.07
Molecular Formula:
C7(13C)3H7Cl2N3O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Labeled Anagrelide. A phosphodiesterase inhibitor with antiplatelet activity that is used as an antithrombocythemic.
Anagrelide-13C3 References
Fleming, J.S., et al.: Thromb. Res., 15, 373 (1979) Seiler, S., et al.: J. Pharmacol. Exp. Ther., 243, 767 (1984) Silverstein, M. N., et al.: N. Engl. J. Med., 318, 1292 (1988) Spencer, C.M., et al.: Drugs, 47, 809 (1994)Inhibitor of:
PDE.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Anagrelide-13C3, 1 mg | sc-217646 | 1 mg | $490.00 |